United States · 
Who invested in Curebase?
Curebase's investors include Y Combinator, Gaingels, Liquid 2 Ventures, Pioneer Fund and Future Planet Capital, and 2 more on record.
United States · Series B startup
Who invested in Curebase
Funding summaryUpdated 26 Oct 2026
$40Mraised across 1 round since 2022, from 1 source
- Latest round
- Series B, $40MMay 2022
- Investors
- 7
The rounds
- May 2022Series B$40M
Source recorded
Founders and team
From Curebase's own website and the SEC filings it signed: 4 on the team.
- Storm StillmanChief Executive Officer
- Scott DixonChief Commercial Officer
- Scott GarciaChief Financial Officer
- Thomas LembergExecutive Officer, Director, Promoteri
On the board, as filediJeff Richards
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
These 3 firms list Curebase as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Curebase
How much has Curebase raised?
Curebase has raised $40M across 1 round since 2022.
When did Curebase last raise?
Curebase's most recent round was a Series B of $40M in May 2022.
What was Curebase's biggest round?
Its most recent round, $40M in May 2022, is also its largest on record.
Who backed Curebase first?
Curebase's first round on record, in May 2022, was backed by Y Combinator, Gaingels and Liquid 2 Ventures and 4 others.
What stage is Curebase at?
Curebase's latest named round is a Series B, in May 2022.
Where is Curebase based?
Curebase is based in the United States.
Companies like Curebase
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.